MedTrace Logo

Ketamine in Bariatric Surgery

NCT01724983 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2012-11-12

No results posted yet for this study

Summary

Ketamine may improve recovery from bariatric surgery.

Conditions

  • Morbid Obesity

Interventions

DRUG

ketamine

DRUG

fentanyl

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Principal Investigators

  • Ulderico Freo, MD · University of Padova

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724983 on ClinicalTrials.gov